About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Evaluating Bifeprunox in Bipolar Depression

NCT00245973·40 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Wyeth is now a wholly owned subsidiary of Pfizer

With

Solvay Pharmaceuticals

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Men and women 18 to 65 years of age, inclusive.
Diagnosis of Bipolar Disorder and must be experiencing a depressive episode.

You may not be if

This is a follow on study to protocol 3168A2-304. Only subjects who have participated in the previous study are eligible.

The record

StatusCompleted

PhasePhase 3

Taking part380

StartedJun 2005

UpdatedDec 5, 2007

Conditions

Depression Bipolar

Where40

Birmingham, Alabama, United States
Beverly Hills, California, United States
National City, California, United States

Clareo Health | Study Evaluating Bifeprunox in Bipolar Depression